Co-occurrence of Two Partially Inactivating Polymorphisms of MC3R Is Associated With Pediatric-Onset Obesity
- Ningping Feng1,
- Sharla F. Young2,
- Greti Aguilera2,
- Elena Puricelli13,
- Diane C. Adler-Wailes1,
- Nancy G. Sebring4 and
- Jack A. Yanovski1
- 1Unit on Growth and Obesity, National Institutes of Health, Bethesda, Maryland
- 2Section on Endocrine Physiology, Developmental Endocrinology Branch, National Institute of Child Health and Development, Rockville, Maryland
- 3Pediatric Department, University of Insubria, Varese, Italy
- 4Nutrition Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland
- Address correspondence and reprint requests to Jack A. Yanovski, MD, PhD, Unit on Growth and Obesity, National Institutes of Health, 10 Center Dr., Hatfield CRC, Rm 1-3330, MSC 1103, Bethesda, MD 20892-1862. E-mail: jy15i{at}nih.gov
Abstract
Both human linkage studies and MC3R knockout mouse models suggest that the MC3R may play an important role in energy homeostasis. Here we show that among 355 overweight and nonoverweight children, 8.2% were double homozygous for a pair of missense MC3R sequence variants (Thr6Lys and Val81Ile). Such children were significantly heavier (BMI and BMI SD score: P < 0.0001), had more body fat (body fat mass and percentage fat mass: P < 0.001), and had greater plasma leptin (P < 0.0001) and insulin concentrations (P < 0.001) and greater insulin resistance (P < 0.008) than wild-type or heterozygous children. Both sequence variants were more common in African-American than Caucasian children. In vitro expression studies found the double mutant MC3R was partially inactive, with significantly fewer receptor binding sites, decreased signal transduction, and less protein expression. We conclude that diminished MC3R expression in this double MC3R variant may be a predisposing factor for excessive body weight gain in children.
- DMEM, Dulbecco’s modified Eagle’s medium
- EGFP, enhanced green fluorescence protein
- FACS, fluorescence-assisted cell sorting
- MSH, melanocyte-stimulating hormone
- NDP α-MSH, (Nle4,D-Phe7) α-melanocyte-stimulating hormone
Footnotes
-
- Accepted June 15, 2005.
- Received February 7, 2005.
- DIABETES














